Owner Glaxo Group Limited

Inventors Nerozzi, Fabrizio; Wyatt, Paul Graham; Sollis, Steven Leslie; Liddle, John; Livermore, David George Hubert; Hickey, Deirdre Mary Bernadette; Szardenings, Anna Katrin; Mason, Andrew McMurtrie; Hatley, Richard Jonathan; Miller, Neil Derek; Borthwick, Alan David

Agent Davies Collison Cave

Pub. Number AU-B-2002364304

PCT Number PCT/EP02/14823

PCT Pub. Number WO2003/053443

Priority 0130677.8 21.12.01 GB

Filing date 20 December 2002

Wipo publication date 9 July 2003

Acceptance publication date 17 April 2008

C07D 241/04 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/5377 (2006.01)

A61K 31/541 (2006.01) - Non-condensed thiazines containing further heterocyclic rings

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 15/06 (2006.01) Drugs for genital or sexual disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 491/113 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/065 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 38/00 (2006.01) Medicinal preparations containing peptides